Correlation Between MORPHOSYS and Provention Bio

Can any of the company-specific risk be diversified away by investing in both MORPHOSYS and Provention Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MORPHOSYS and Provention Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MORPHOSYS and Provention Bio, you can compare the effects of market volatilities on MORPHOSYS and Provention Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MORPHOSYS with a short position of Provention Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of MORPHOSYS and Provention Bio.

Diversification Opportunities for MORPHOSYS and Provention Bio

0.0

Correlation Coefficient

MORPHOSYS  Provention Bio

Pay attention - limited upside

The 3 months correlation between MORPHOSYS and Provention is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding MORPHOSYS and Provention Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Provention Bio and MORPHOSYS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MORPHOSYS are associated (or correlated) with Provention Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Provention Bio has no effect on the direction of MORPHOSYS i.e., MORPHOSYS and Provention Bio go up and down completely randomly.

Pair Corralation between MORPHOSYS and Provention Bio

If you would invest (100.00) in Provention Bio on August 15, 2025 and sell it today you would earn a total of  100.00  from holding Provention Bio or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

MORPHOSYS  vs.  Provention Bio

MORPHOSYS

Risk-Adjusted Performance

Weakest

Over the last 90 days MORPHOSYS has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, MORPHOSYS is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Provention Bio

Risk-Adjusted Performance

Weakest

Over the last 90 days Provention Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Provention Bio is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with MORPHOSYS and Provention Bio

The main advantage of trading using opposite MORPHOSYS and Provention Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MORPHOSYS position performs unexpectedly, Provention Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Provention Bio will offset losses from the drop in Provention Bio's long position.

The idea behind MORPHOSYS and Provention Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.